fluspirilene has been researched along with Basal Ganglia Diseases in 4 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wise, LD | 1 |
| Pattison, IC | 1 |
| Butler, DE | 1 |
| DeWald, HA | 1 |
| Lewis, EP | 1 |
| Lobbestael, SJ | 1 |
| Nordin, IC | 1 |
| Poschel, BP | 1 |
| Coughenour, LL | 1 |
| Magnus, RV | 1 |
| Heinrich, K | 1 |
| Lehmann, E | 1 |
| Chouinard, G | 1 |
| Annable, L | 1 |
| Steinberg, S | 1 |
2 trials available for fluspirilene and Basal Ganglia Diseases
| Article | Year |
|---|---|
Low dose neuroleptanxiolysis in anxiety states.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Basal Ganglia Diseases; Bromazepam; Dose-Response Relationship, | 1992 |
A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
Topics: Adult; Age Factors; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Double-Blind M | 1986 |
2 other studies available for fluspirilene and Basal Ganglia Diseases
| Article | Year |
|---|---|
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profiles.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Catalepsy; Corpus Stria | 1985 |
[Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
Topics: Basal Ganglia Diseases; Delayed-Action Preparations; Female; Fluphenazine; Fluspirilene; Humans; Mal | 1980 |